[go: up one dir, main page]

BRPI0816158A2 - composto carbociclo fundido substituído com heterociclila e uso do mesmo. - Google Patents

composto carbociclo fundido substituído com heterociclila e uso do mesmo.

Info

Publication number
BRPI0816158A2
BRPI0816158A2 BRPI0816158A BRPI0816158A BRPI0816158A2 BR PI0816158 A2 BRPI0816158 A2 BR PI0816158A2 BR PI0816158 A BRPI0816158 A BR PI0816158A BR PI0816158 A BRPI0816158 A BR PI0816158A BR PI0816158 A2 BRPI0816158 A2 BR PI0816158A2
Authority
BR
Brazil
Prior art keywords
heterocyclyl
substituted fused
fused carbocycle
compound
carbocycle compound
Prior art date
Application number
BRPI0816158A
Other languages
English (en)
Inventor
W Gil Daniel
Chow Ken
E Garst Michael
C Sinha Santosh
S Bhat Smita
M Heidelbaugh Todd
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0816158A2 publication Critical patent/BRPI0816158A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0816158A 2007-08-15 2008-08-14 composto carbociclo fundido substituído com heterociclila e uso do mesmo. BRPI0816158A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95597207P 2007-08-15 2007-08-15
PCT/US2008/073110 WO2009023758A1 (en) 2007-08-15 2008-08-14 Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain

Publications (1)

Publication Number Publication Date
BRPI0816158A2 true BRPI0816158A2 (pt) 2017-06-13

Family

ID=39865281

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0816158A BRPI0816158A2 (pt) 2007-08-15 2008-08-14 composto carbociclo fundido substituído com heterociclila e uso do mesmo.

Country Status (10)

Country Link
US (2) US8426454B2 (pt)
EP (1) EP2188262A1 (pt)
JP (1) JP2010536781A (pt)
KR (1) KR20100071990A (pt)
CN (1) CN101855212A (pt)
AU (1) AU2008286824B2 (pt)
BR (1) BRPI0816158A2 (pt)
CA (1) CA2696315A1 (pt)
RU (1) RU2481335C2 (pt)
WO (1) WO2009023758A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101855212A (zh) 2007-08-15 2010-10-06 阿勒根公司 可用于治疗例如青光眼和疼痛的病症的杂环取代的稠合碳环
JP2010536780A (ja) * 2007-08-15 2010-12-02 アラーガン インコーポレイテッド 治療化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870161A (en) 1957-07-08 1959-01-20 Pfizer & Co C 2-(1-indanyl amino)-oxazolines
US2870159A (en) * 1957-07-08 1959-01-20 Pfizer & Co C Hydrogenated 2-(1-naphthylamino)-oxazolines
US2883410A (en) 1957-07-08 1959-04-21 Pfizer & Co C N-(1-indanyl)-n'-(beta-substituted ethyl)-ureas
US3636219A (en) * 1964-03-02 1972-01-18 Du Pont Anticholinergic compositions containing certain thiazolines or imidazolines
DE1963192A1 (de) 1969-12-17 1971-06-24 Bayer Ag Ektoparasiticide Mittel
AT330769B (de) * 1974-04-05 1976-07-26 Chemie Linz Ag Verfahren zur herstellung von 2-arylamino- 2-imidazolin-derivaten und ihren salzen
US4256755A (en) * 1980-04-28 1981-03-17 E. I. Du Pont De Nemours & Company Method of using N-substituted dihydro-2-oxazolamines as analgesics
GB8610909D0 (en) * 1986-05-03 1986-06-11 Beecham Group Plc Compounds
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
JPH11505224A (ja) * 1995-05-12 1999-05-18 アラーガン 心臓血管系副作用を伴わないα▲下2▼アドレナリン作動剤として有用なアリール−イミダゾリンおよびアリール−イミダゾール
US7141597B2 (en) 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
JPWO2005055999A1 (ja) * 2003-12-08 2007-07-05 日本新薬株式会社 抗コリン作用剤
GB0516706D0 (en) * 2005-08-15 2005-09-21 Syngenta Participations Ag Chemical compounds
PE20070705A1 (es) * 2005-11-25 2007-08-23 Basf Ag Compuestos de indanil - y tetrahidronaftil-amino-azolina para combatir pestes animales
AU2007214826A1 (en) * 2006-02-15 2007-08-23 Bayer Cropscience Ag Insecticidal substituted amino heterocyclic and heteroaryl derivatives
WO2008115141A1 (en) * 2007-03-19 2008-09-25 Albireo Ab 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders
CN101855212A (zh) 2007-08-15 2010-10-06 阿勒根公司 可用于治疗例如青光眼和疼痛的病症的杂环取代的稠合碳环
JP2010536780A (ja) * 2007-08-15 2010-12-02 アラーガン インコーポレイテッド 治療化合物

Also Published As

Publication number Publication date
US20110178144A1 (en) 2011-07-21
RU2481335C2 (ru) 2013-05-10
CN101855212A (zh) 2010-10-06
US8426454B2 (en) 2013-04-23
EP2188262A1 (en) 2010-05-26
AU2008286824A1 (en) 2009-02-19
AU2008286824B2 (en) 2014-10-02
US8815923B2 (en) 2014-08-26
JP2010536781A (ja) 2010-12-02
CA2696315A1 (en) 2009-02-19
RU2010108386A (ru) 2011-09-20
US20130217739A1 (en) 2013-08-22
KR20100071990A (ko) 2010-06-29
WO2009023758A1 (en) 2009-02-19

Similar Documents

Publication Publication Date Title
BRPI0821668A2 (pt) Uso
BRPI0807388A2 (pt) Instrumento de escrita termocromática.
FR2909857B1 (fr) Endovalve.
ATE513831T1 (de) Pyridinä3,4-büpyrazinone
ATE490873T1 (de) Ringordnermechanismus
DE602006016993D1 (de) Gleitelement
BRPI0807991A2 (pt) Anticorpos anti-il-23r elaborados.
FR2900034B1 (fr) Poudrier.
DE112006004211A5 (de) Bohrfutter
DE602007009260D1 (de) Zwischenhülse
EP2202090A4 (en) MECHANICAL PIN
DE112007003149A5 (de) Spannfutter
BRPI0818645A2 (pt) Lápis
DE112007000530A5 (de) Kopfplatte
FR2923713B1 (fr) Composition reductrice epaissie.
FR2913338B1 (fr) Composition de rehydratation.
BRPI0816158A2 (pt) composto carbociclo fundido substituído com heterociclila e uso do mesmo.
ATE488416T1 (de) Bob
DE112007001763A5 (de) Schaltungsanordnung
ITCE20060002A1 (it) Patok.
ES1062424Y (es) Sombrilla.
FI7246U1 (fi) Kynä
TH94168B (th) ปากกา
FIU20060430U0 (fi) Järjestelijä
ES1060537Y (es) Boligrafo

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)